Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2008
10/01/2008CN101274929A Thrombin receptor antagonists
10/01/2008CN101274918A Substitutive five membered heterocyclic compound, preparation and medical use thereof
10/01/2008CN100422171C Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/01/2008CN100422158C Inhibitors of Akt activity
10/01/2008CN100422156C Isoquinolinium compound, producing method and application of its salt
10/01/2008CN100422151C Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/01/2008CN100421665C Mitotic kinesin inhibitors
09/2008
09/30/2008US7429660 Induce immunology response; anticancer agents
09/30/2008US7429609 Pyrazole compound and medicinal composition containing the same
09/30/2008US7429604 Six-membered heterocycles useful as serine protease inhibitors
09/30/2008US7429601 Tropan-6exo-yl benzilate methobromide or a physiologically acceptable salt or derivative; chronic obstructive pulmonary disease, asthma; urogenital disorders; antihistamine, antispasmodic, and bronchodilator agents
09/30/2008US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
09/30/2008US7429597 Heterobicyclic compound such as quinazoline anticoagulants and factor X inhibitors
09/30/2008US7429593 Utilities of amide compounds
09/30/2008US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
09/30/2008US7429581 Pyrazole-derivatives as factor Xa inhibitors
09/30/2008US7429579 antagonism/inhibition, of the D3 receptor; substance abuse.
09/30/2008US7429565 Antiviral phosphonate analogs
09/30/2008CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
09/30/2008CA2303848C Substituted anilides
09/25/2008WO2008115381A1 Pyridazinone derivatives useful as glucan synthase inhibitors
09/25/2008WO2008114023A2 Phthalazinone derivatives
09/25/2008WO2008097428A3 Compounds and compositions as modulators of gpr119 activity
09/25/2008US20080234349 PPAR active compounds
09/25/2008US20080234278 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
09/25/2008US20080234250 Heterocyclic Condensed Compounds Useful as Antidiuretic Agents
09/25/2008US20080234247 Heterocyclic analgesic compounds and methods of use thereof
09/25/2008US20080234237 selectively inhibit neuronal nitric oxide synthase in combination with other pharmaceutically active agents; antidepressants
09/25/2008CA2680583A1 Pyridazinone derivatives useful as glucan synthase inhibitors
09/24/2008EP1972623A1 Arylpyridazines as fungicides
09/24/2008EP1971664A1 Emitting materials and organic light emitting device using the same
09/24/2008EP1971599A1 Antiviral 2-carboxy-thiophene compounds
09/24/2008EP1971581A1 Piperazine compounds with a herbicidal action
09/24/2008EP1971580A1 Piperazine compounds with a herbicidal action
09/24/2008EP1971576A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
09/24/2008EP1723116B1 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/24/2008EP1513520B1 Substituted pyrrolines as kinase inhibitors
09/24/2008EP1322650B1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
09/24/2008CN101273035A Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
09/24/2008CN101273034A Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
09/23/2008US7427683 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer
09/23/2008US7427682 Indole derivatives as selective androgen receptor modulators (SARMS)
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427636 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups
09/23/2008US7427632 Factor Xa inhibitors
09/23/2008US7427631 especially as inhibitors of MMP12
09/23/2008US7427626 useful in Pharmaceutical medicines or pharmacological tools; cytostatic agents; antiproliferative/antineoplastic agents; 2-Anilino-4-[1-isopropyl-2-(hydroxyiminomethyl)imidazol-5-yl]pyrimidine; rheumatoid arthritis; breast cancer
09/23/2008CA2480800C Inhibitors of akt activity
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors
09/23/2008CA2337825C Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions
09/23/2008CA2293373C Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
09/18/2008WO2008112022A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
09/18/2008WO2008111632A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative
09/18/2008WO2008111414A1 Catalyst composition, and process for production of cross-coupling compound using the same
09/18/2008WO2008111300A1 Novel diamide derivative
09/18/2008WO2008111299A1 Novel diamide derivative
09/18/2008WO2008110793A1 Piperidinones useful in the treatment of inflammation
09/18/2008WO2008110355A1 Quinoline derivatives as fungicides
09/18/2008WO2008110308A2 Novel herbicides
09/18/2008WO2008110307A1 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides
09/18/2008WO2008109991A1 Inhibitors of carnitine palmitoyltransferase and treating cancer
09/18/2008WO2008074832A3 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase ( scd)
09/18/2008US20080227981 Charge transport compositions and electronic devices made with such compositions
09/18/2008US20080227839 Kinase Inhibitors
09/18/2008US20080227814 Ethanolamine derivatives such as 6-hydroxy-1-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-(p-methylsulfonylphenyl)tetralin and 6-hydroxy-2-(p-(trifluoromethyl)phenyl)-3-(p-(2-(1-piperidinyl)ethoxy)benzoyl)benzothiophene; treating endometriosis and uterine leiomyoma.
09/18/2008US20080227793 2-(1-Imidazomethyl)- or 2-(1-imidazooxy)-substituted, e.g., 6-chloro-2-{[2-(2-fluorophenyl)-1H-imidazol-1-yl]methyl}-1-propyl1H-benzimidazole; GABA receptor signal transduction; anxiety, antidepressants, sleep disorders, schizophrenia, attention deficit-hyperactivity disorder, memory enhancement
09/18/2008US20080227785 BEC 1 potassium channel inhibitors, used to treat dementia and learning disorders; e.g., N-(4-fluorophenyl)-N'-isopropyl-N''-phenyl-1,3,5-triazine-2,4,6-triamine hydrochloride
09/18/2008CA2680412A1 Piperidinones useful in the treatment of inflammation
09/18/2008CA2680366A1 Inhibitors of carnitine palmitoyltransferase and treating cancer
09/18/2008CA2680360A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
09/18/2008CA2679714A1 Quinoline derivatives as fungicides
09/18/2008CA2679343A1 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides
09/18/2008CA2679194A1 Novel herbicides
09/17/2008EP1970375A1 Arylmethylene urea derivative and use thereof
09/17/2008EP1968969A2 Organic compounds
09/17/2008EP1968947A1 Gaba-b receptor modulators
09/17/2008EP1968940A1 3 , 5-substitued piperidine compounds as renin inhibitors
09/17/2008EP1495003B1 Fredericamycin derivatives
09/17/2008EP1325910B1 Aliphatic nitrogenous five-membered ring compounds
09/17/2008CN101268072A DNA-PK inhibitors
09/17/2008CN101268064A Pyrazine derivatives useful as adenosine receptor antagonists
09/17/2008CN101268063A Thiophene derivatives for the treatment of diabetes
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/16/2008US7425638 Cis-imidazolines
09/16/2008US7425631 Compounds and methods of use
09/16/2008US7425564 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same
09/16/2008US7425563 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline
09/16/2008US7425553 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
09/16/2008CA2515338C Inhibitors of histone deacetylase
09/16/2008CA2427221C Process and intermediates for preparing anti-cancer compounds
09/16/2008CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
09/12/2008WO2008109336A1 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor
09/12/2008WO2008109179A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008109178A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008108730A1 Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709
09/12/2008WO2008108486A1 1-biarylazetidinone derivatives
09/12/2008WO2008108380A2 Pyrrole compounds
09/12/2008WO2008107480A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
09/12/2008WO2008107321A1 Heterocyclic compounds used as anti-neoplasic agents or cell proliferation inhibitors